<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>All About Cardiovascular System and Disorders</provider_name><provider_url>https://johnsonfrancis.org/professional</provider_url><author_name>Johnson Francis</author_name><author_url>https://johnsonfrancis.org/professional/author/jf/</author_url><title>Drug provocation in Brugada syndrome - All About Cardiovascular System and Disorders</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="k2634taOpn"&gt;&lt;a href="https://johnsonfrancis.org/professional/drug-provocation-in-brugada-syndrome/"&gt;Drug provocation in Brugada syndrome&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://johnsonfrancis.org/professional/drug-provocation-in-brugada-syndrome/embed/#?secret=k2634taOpn" width="600" height="338" title="&#x201C;Drug provocation in Brugada syndrome&#x201D; &#x2014; All About Cardiovascular System and Disorders" data-secret="k2634taOpn" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://johnsonfrancis.org/professional/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://johnsonfrancis.org/professional/wp-content/uploads/2014/10/cardiology-mcq5.png</thumbnail_url><thumbnail_width>701</thumbnail_width><thumbnail_height>517</thumbnail_height><description>Which of the following is not used in provocative testing for Brugada syndrome? a) Ajmaline b) Isoprenaline c) Flecainide d) Procainamide Correct answer: b) Isoprenaline ST elevation in Brugada syndrome is quite variable and may need drug challenge for unmasking. Isoprenaline is not used for provocative testing in Brugada syndrome, though it is often used [&hellip;]</description></oembed>
